Canadian Medical Center Co. (CMCER) reported a net profit after Zakat and tax of SAR 7.9 million in H1 2022, an increase of 60% compared to nearly SAR 5 million in the prior-year period.
Item | 6m 2021 | 6m 2022 | Change |
---|---|---|---|
Revenues | 30.18 | 38.92 | 28.9 % |
Gross Income | 12.39 | 12.63 | 1.9 % |
Operating Income | 6.51 | 9.11 | 40.1 % |
Net Income | 4.96 | 7.94 | 59.9 % |
Average Shares | 77.00 | 77.00 | - |
EPS (Riyals) | 0.06 | 0.10 | 59.9 % |
The increase was mainly driven by higher operating revenue.
Item | H1 2021 | H1 2022 | Change |
---|---|---|---|
Revenues | 30.18 | 38.92 | 28.9 % |
Gross Income | 12.39 | 12.63 | 1.9 % |
Operating Income | 6.51 | 9.11 | 40.1 % |
Net Income | 4.96 | 7.94 | 59.9 % |
Average Shares | 77.00 | 77.00 | - |
EPS (Riyals) | 0.06 | 0.10 | 59.9 % |
Item | H2 2021 | H1 2022 | Change |
---|---|---|---|
Revenues | 40.46 | 38.92 | (3.8 %) |
Gross Income | 12.80 | 12.63 | (1.3 %) |
Operating Income | 9.80 | 9.11 | (7.0 %) |
Net Income | 9.10 | 7.94 | (12.8 %) |
Average Shares | 77.00 | 77.00 | - |
EPS (Riyals) | 0.12 | 0.10 | (12.8 %) |
Total shareholders’ equity, excluding minority interest, stood at SAR 90.51 million as of June 30, 2022, compared to SAR 97 million in the year-earlier period.
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
H1 2013 | - | - | - | - | - | - |
H2 2013 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
H1 2014 | - | - | - | - | - | - |
H2 2014 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
H1 2015 | - | - | - | - | - | - |
H2 2015 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
H1 2016 | - | - | - | - | - | - |
H2 2016 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
H1 2017 | - | - | - | - | - | - |
H2 2017 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
H1 2018 | - | - | - | - | - | - |
H2 2018 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
H1 2019 | - | - | - | - | - | - |
H2 2019 | - | - | - | - | - | - |
2019 | 53.56 | - | 21.29 | - | 16.30 | - |
H1 2020 | 29.83 | - | 12.22 | - | 8.72 | - |
H2 2020 | 34.38 | - | 11.80 | - | 8.44 | - |
2020 | 64.22 | 19.9 % | 24.03 | 12.9 % | 17.16 | 5.3 % |
H1 2021 | 30.18 | 1.2 % | 12.39 | 1.4 % | 6.51 | (25.4 %) |
H2 2021 | 40.46 | 17.7 % | 12.80 | 8.4 % | 9.80 | 16.0 % |
2021 | 70.64 | 10.0 % | 25.19 | 4.9 % | 16.30 | (5.0 %) |
H1 2022 | 38.92 | 28.9 % | 12.63 | 1.9 % | 9.11 | 40.1 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2012 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
2019 | 53.56 | - | 21.29 | - | 16.30 | - |
2020 | 64.22 | 19.9 % | 24.03 | 12.9 % | 17.16 | 5.3 % |
2021 | 70.64 | 10.0 % | 25.19 | 4.9 % | 16.30 | (5.0 %) |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
H1 2013 | - | - | - | - | - | - |
H2 2013 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
H1 2014 | - | - | - | - | - | - |
H2 2014 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
H1 2015 | - | - | - | - | - | - |
H2 2015 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
H1 2016 | - | - | - | - | - | - |
H2 2016 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
H1 2017 | - | - | - | - | - | - |
H2 2017 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
H1 2018 | - | - | - | - | - | - |
H2 2018 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
H1 2019 | - | - | - | - | - | - |
H2 2019 | - | - | - | - | - | - |
2019 | 14.87 | - | 0.19 | - | 14.87 | 0.19 |
H1 2020 | 8.40 | - | 0.11 | - | 8.40 | 0.11 |
H2 2020 | 7.75 | - | 0.10 | - | 7.75 | 0.10 |
2020 | 16.15 | 8.6 % | 0.21 | - | 16.15 | 0.21 |
H1 2021 | 4.96 | (40.9 %) | 0.06 | - | 4.96 | 0.06 |
H2 2021 | 9.10 | 17.4 % | 0.12 | - | 9.10 | 0.12 |
2021 | 14.06 | (12.9 %) | 0.18 | - | 14.06 | 0.18 |
H1 2022 | 7.94 | 59.9 % | 0.10 | - | 7.94 | 0.10 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2012 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
2019 | 14.87 | - | 0.19 | - | 14.87 | 0.19 |
2020 | 16.15 | 8.6 % | 0.21 | - | 16.15 | 0.21 |
2021 | 14.06 | (12.9 %) | 0.18 | - | 14.06 | 0.18 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
H1 2013 | - | - | - |
H2 2013 | - | - | - |
2013 | - | - | - |
H1 2014 | - | - | - |
H2 2014 | - | - | - |
2014 | - | - | - |
H1 2015 | - | - | - |
H2 2015 | - | - | - |
2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
2019 | 39.75 % | 33.03 % | 27.77 % |
H1 2020 | - | - | - |
H2 2020 | 37.42 % | 31.13 % | 25.15 % |
2020 | 37.42 % | 31.13 % | 25.15 % |
H1 2021 | 37.48 % | 28.00 % | 19.70 % |
H2 2021 | 35.66 % | 27.24 % | 19.91 % |
2021 | 35.66 % | 27.24 % | 19.91 % |
H1 2022 | 32.04 % | 27.32 % | 21.47 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2012 | - | - | - |
2013 | - | - | - |
2014 | - | - | - |
2015 | - | - | - |
2016 | - | - | - |
2017 | - | - | - |
2018 | - | - | - |
2019 | 39.75 % | 33.03 % | 27.77 % |
2020 | 37.42 % | 31.13 % | 25.15 % |
2021 | 35.66 % | 27.24 % | 19.91 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
H1 2013 | - | - | - |
H2 2013 | - | - | - |
H1 2014 | - | - | - |
H2 2014 | - | - | - |
H1 2015 | - | - | - |
H2 2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
H1 2020 | 40.97 % | 32.99 % | 28.15 % |
H2 2020 | 34.33 % | 29.52 % | 22.55 % |
H1 2021 | 41.06 % | 26.26 % | 16.44 % |
H2 2021 | 31.64 % | 27.96 % | 22.49 % |
H1 2022 | 32.45 % | 26.66 % | 20.40 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
H1 2013 | - | - | - | - |
H2 2013 | - | - | - | - |
H1 2014 | - | - | - | - |
H2 2014 | - | - | - | - |
H1 2015 | - | - | - | - |
H2 2015 | - | - | - | - |
H1 2016 | - | - | - | - |
H2 2016 | - | - | - | - |
H1 2017 | - | - | - | - |
H2 2017 | - | - | - | - |
H1 2018 | - | - | - | - |
H2 2018 | - | - | - | - |
H1 2019 | - | - | - | - |
H2 2019 | - | - | - | - |
H1 2020 | 77.00 | - | - | 0.19 |
H2 2020 | 77.00 | 0.21 | 0.21 | 1.20 |
H1 2021 | 77.00 | 0.17 | 0.17 | 1.26 |
H2 2021 | 77.00 | 0.18 | 0.18 | 1.23 |
H1 2022 | 77.00 | 0.22 | 0.22 | 1.18 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2012 | - | - | - | - |
2013 | - | - | - | - |
2014 | - | - | - | - |
2015 | - | - | - | - |
2016 | - | - | - | - |
2017 | - | - | - | - |
2018 | - | - | - | - |
2019 | 77.00 | 0.19 | 0.19 | 0.15 |
2020 | 77.00 | 0.21 | 0.21 | 1.20 |
2021 | 77.00 | 0.18 | 0.18 | 1.23 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
H1 2013 | - | - | - |
H2 2013 | - | - | - |
H1 2014 | - | - | - |
H2 2014 | - | - | - |
H1 2015 | - | - | - |
H2 2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
H1 2020 | - | - | - |
H2 2020 | - | - | - |
H1 2021 | - | - | - |
H2 2021 | 47.36 | 47.36 | 7.05 |
H1 2022 | 22.96 | 22.96 | 4.32 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2012 | - | - | - |
2013 | - | - | - |
2014 | - | - | - |
2015 | - | - | - |
2016 | - | - | - |
2017 | - | - | - |
2018 | - | - | - |
2019 | - | - | - |
2020 | - | - | - |
2021 | 47.36 | 47.36 | 7.05 |
2022
2022
Period | Medical Clinics Sector | Medical Clinics Project Contracts Sector |
---|
Period | Medical Clinics Sector | Medical Clinics Project Contracts Sector |
---|---|---|
2020 | 2.02 | 62.20 |
2021 | 1.93 | 68.72 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}